Abstract
The stepwise protonation of ethylenediamine-containing peptides at low pH in endosomes is hypothesized to disrupt the endosomal membrane and enhance cytosolic delivery. Incorporation of a novel glutamic acid analog bearing an ethylenediamine moiety into TAT peptides markedly enhanced cytosolic delivery without cytotoxicity.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
